Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Recombinant IFN-beta-1a from Ares-Serono reduces relapses, delays progression in MS

Dec. 2, 1997

Dopamine receptor subtype-specific ligands prepared at Neurogen

Dec. 2, 1997

Fujisawa isolates novel calpain inhibitors

Dec. 2, 1997

New anesthetic agent in phase I at Synthelabo

Dec. 1, 1997

Effects of AE-0047 on cerebral ischemia/edema and renal injury

Dec. 1, 1997

Esteve presents new calcium antagonists with potential as neuroprotectants

Dec. 1, 1997

Biological profile of the potent, selective dopamine D4 antagonist L-745870

Nov. 28, 1997

Results of large dose-finding study on rizatriptan in migraine reported

Nov. 28, 1997

Glutamate antagonists discovered at BASF

Nov. 28, 1997

The new frontier in medical research: prion diseases

Nov. 28, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 7, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...